Last reviewed · How we verify
PL 3100
At a glance
| Generic name | PL 3100 |
|---|---|
| Also known as | Naproxen-PC |
| Sponsor | PLx Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Oral Bioequivalence Study of PL 3100 and Naproxen in Healthy Adults (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |